Literature DB >> 22654223

Phytochemical and biological investigations of Atriplex semibacata R .BR. growing in Egypt.

Wafaa A Tawfik1, Mona M Abdel-Mohsen, Hany M Radwan, Amira A Habib, M A Yeramian.   

Abstract

The lipid content of Atriplex semibacata growing in Egypt was studied. The unsaponifiable fraction was identified by GLC. A series of hydrocarbons ranging from C(14)- C(28) in addition to cholesterol, stigmasterol and the triterpenoids α and β - amyrin were identified. GLC analysis of fatty alcohols fraction revealed the presence of six fatty alcohols in which dotriacontanol (C(32)H(66)O) was the major (14.68%). Six compounds (five coumarins and one phenolic acid) were isolated for the first time from A. semibacata. The coumarin constituents isolated from the chloroform and the ethyl acetate fractions of the aqueous alcoholic extract of A. semibacata were identified as scopoletin, umbelliferorne, coumarin, scopolin, 7-methoxy coumarin in addition to a phenolic acid P-coumaric acid. Also, the flavonoidal compounds isolated from the n-butanol fraction of the plant revealed the presence of kaempferol 3-O glucoside and acacetin. Their identity was proved by m.p., TLC, PC, UV and MS analysis. The alcohol extract showed significant antimicrobial activity against G-ve bacteria, moderate activity against G+ve bacteria. On the other hand, the pet. Ether extract showed marked activity against G+ve bacteria and fungi, also the G-ve bacteria was greatly inhibited by the chloroform extract. The different extracts of the plant exhibited no cytotoxic activity against Erlich-ascites carcinoma cells line at the tested concentrations, also showed a strong antioxidant activity using DPPH.

Entities:  

Keywords:  Atriplex semibacata; antifungal; antimicrobial; antioxidant; antitumor; coumarins; fatty alcohols; flavonoids; unsaponifiable fraction

Mesh:

Substances:

Year:  2011        PMID: 22654223      PMCID: PMC3218464          DOI: 10.4314/ajtcam.v8i4.15

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  8 in total

1.  A new flavonoid from the aerial part of Thalictrum atriplex.

Authors:  G Guangyao; C Sibao; Y Junshan; X Peigen
Journal:  Fitoterapia       Date:  2000-12       Impact factor: 2.882

2.  [Studies on chemical constituents of Thalictrum atriplex Finet et Gagnep].

Authors:  G Gao; S Chen; L Wang; M Liao; S Yu; P Xiao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  1999-03

3.  Plants used for the treatment of diabetes in Israel.

Authors:  Z Yaniv; A Dafni; J Friedman; D Palevitch
Journal:  J Ethnopharmacol       Date:  1987 Mar-Apr       Impact factor: 4.360

4.  Molluscicidal activity of Fagonia cretica and Atriplex leucoclada.

Authors:  H A Shoeb; M A el-Emam; A M Saad; M A Mohamed
Journal:  J Egypt Soc Parasitol       Date:  1987-12

5.  [Studies on the chemical constituents of Securidaca inappendiculata].

Authors:  Xue-dong Yang; Li-zhen Xu; Shi-lin Yang
Journal:  Yao Xue Xue Bao       Date:  2002-05

6.  Titerpenoid saponins from Atriplex semibaccata.

Authors:  Kamel H Shaker; Katja Dockendorff; Karlheinz Seifert
Journal:  Z Naturforsch C J Biosci       Date:  2003 Jul-Aug

7.  HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-diphenyl-2-picrylhydrazyl.

Authors:  T Yamaguchi; H Takamura; T Matoba; J Terao
Journal:  Biosci Biotechnol Biochem       Date:  1998-06       Impact factor: 2.043

8.  [Biologic value of the protein concentrate of Atripex lampa and its value as a complement to wheat flour].

Authors:  S I de Mucciarelli; J A Cid; M A de Arellano; S Fernández; N G de Lúquez; J E Muzaber
Journal:  Arch Latinoam Nutr       Date:  1988-12
  8 in total
  1 in total

1.  In Vivo Antiplasmodial Potential of the Leaf, Mesocarp, and Epicarp of the Raphia hookeri Plant in Mice Infected with Plasmodium berghei NK65.

Authors:  Abimbola Peter Oluyori; Charles Nwonuma; Theresa Akpo; Adejumoke Abosede Inyinbor; Oluwasogo Adewumi Dada; Oluwole Solomon Oladeji; Temitope Aminat Ogunnupebi
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-13       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.